scispace - formally typeset
Journal ArticleDOI

Contribution of astrocytes to neuropathology of neurodegenerative diseases.

Cigdem Acioglu, +2 more
- 28 Jan 2021 - 
- Vol. 1758, pp 147291-147291
Reads0
Chats0
TLDR
A review of the contribution of microglia to neurodegenerative diseases with particular emphasis on Alzheimer's disease, Parkinson disease, amyotrophic lateral sclerosis and frontotemporal dementia is presented in this paper.
About
This article is published in Brain Research.The article was published on 2021-01-28. It has received 43 citations till now. The article focuses on the topics: Neuroprotection & Neuroinflammation.

read more

Citations
More filters
Journal ArticleDOI

A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?

TL;DR: Astrocytes play a pivotal role in maintaining the central nervous system (CNS) homeostasis and function, and reactive astrocytes are triggered in response to CNS injuries and diseases as mentioned in this paper.
Journal ArticleDOI

Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications

TL;DR: In this paper , the implications of microglia and astrocytes in AD pathogenesis are discussed, and the mechanisms of therapeutic agents that exhibit anti-inflammatory effects against AD are discussed.
Journal ArticleDOI

First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis

TL;DR: 18F-SMBT-1 showed robust entry into the brain and reversible binding kinetics, with high tracer retention in basal ganglia, intermediate retention in cortical regions, and the lowest retention in cerebellum and white matter, which tightly follows the known regional brain distribution of MAO-B.
Journal ArticleDOI

Dysregulation of Astrocyte–Neuronal Communication in Alzheimer’s Disease

TL;DR: In this article, the role of astrocytes at synapses in Alzheimer's disease has been investigated, and it was shown that their role in regulating synaptic plasticity and neuronal excitability via the release of neuroactive substances named gliotransmitters.
Journal ArticleDOI

Assessing Reactive Astrogliosis with 18F-SMBT-1 Across the Alzheimer Disease Spectrum

TL;DR: It is suggested that increased 18F-SMBT-1 binding is detectable at the preclinical stages of Aβ accumulation, providing strong support for its use as a surrogate marker of astrogliosis in the AD continuum.
References
More filters
Journal ArticleDOI

Neuropathological stageing of Alzheimer-related changes.

Heiko Braak, +1 more
TL;DR: The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations, permitting the differentiation of six stages.
Journal ArticleDOI

Pattern Recognition Receptors and Inflammation

TL;DR: The role of PRRs, their signaling pathways, and how they control inflammatory responses are discussed.
Journal ArticleDOI

Alzheimer's Disease: Genes, Proteins, and Therapy

TL;DR: Evidence that the presenilin proteins, mutations in which cause the most aggressive form of inherited AD, lead to altered intramembranous cleavage of the beta-amyloid precursor protein by the protease called gamma-secretase has spurred progress toward novel therapeutics and provided discrete biochemical targets for drug screening and development.
Related Papers (5)
Trending Questions (2)
Why are neurons a better target for neurodegenerative diseases than astrocytes?

The provided paper does not directly address why neurons are a better target for neurodegenerative diseases than astrocytes. The paper focuses on the contribution of astrocytes to neurodegenerative diseases and their potential as therapeutic targets.

Are neurons a better target for neurodegenerative diseases than astrocytes?

The paper does not directly compare neurons and astrocytes as targets for neurodegenerative diseases. The paper focuses on the contribution of astrocytes to neurodegenerative diseases and suggests that astrocytes are potential new targets for therapeutic interventions.